Prime Therapeutics Launches IntegratedRx – Oncology, Partners on MIP Accreditation

Many people fighting cancer must get their oral oncolytics from a central fill specialty pharmacy, which can add to the time it takes for a prescription to be filled, as well as potential waste when an oncologist changes a medication. Prime Therapeutics LLC recently unveiled a new program known as IntegratedRx – Oncology that the PBM says will help coordinate care for members and streamline the treatment process.

Prime serves more than 33 million people. It is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

Angela Maas

Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy (formerly called Specialty Pharmacy News) since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at HemAware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/07/Specialty_Pharmacy_Prime_Rolls_Out_New.jpg
July 8

Prime Rolls Out New Medical Benefit Management Offering

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-radar-on-drug-benefits-Prime-Therapeutics-Taps-Amazon-for-Home-Delivery.jpg
October 14

Prime Therapeutics Taps Amazon for Home Delivery

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/08/post-default-img.jpg
September 10

Prime Therapeutics Rolls Out New Real Time Benefit Tool

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today